The Jon Holden DeHaan Foundation, d.b.a. the Jon DeHaan Foundation, proudly supports those working to advance cardiac medicine. The Foundation's Award for Innovation in Cardiology provides funding to individuals and companies who focus on commercializing innovative developments in cardiovascular medicine, including research, prevention, diagnosis, treatment, or rehabilitation.
MAKING A DIFFERENCE
TCT SHARK TANK 2020
On Sight Medical
"The On Sight team truly appreciates the outstanding generosity and support we received form Mr. DeHaan and the foundation. This grant enables On Sight to bring Ultrasound capabilities to the novice user, which results in improved patient care, particularly in rural areas, underserved populations, and developing countries. It is making a significant impact on the screening, analysis, monitoring, and diagnosis of cardiac disease."
Dr. Achi Ludomirsky, MD
Co-Founder & CMO
ICI MEETING 2019
"On behalf of myself and the Healium Medical team we would like to express our deep appreciation for being selected winner of the Jon DeHaan Foundation Innovation Award at the ICI2019 conference.
This prestigious award is a recognition in the importance of our journey aimed at providing improved care to patients suffering from atrial fibrillation using our advanced No-Contact Guided Ultrasound Ablation technology.
Using this outstanding award we intend to continue and accelerate the development of our ultrasound technology with the strong hope and vision to offer improved outcomes to atrial fibrillation patients undergoing catheter ablation procedures"
Ran Sela, CEO
"On behalf of our entire company, Fletcher and I wanted thank Mr. DeHaan personally for his support for the Shark Tank Competition and the innovation it recognizes, and we’ll reflect on this often as one of the high-points in the life of InterVene."
Jeff Elkins, COO and Fletcher Wilson, Founder/CEO
Dr. Jonathon Leipsic
"We intended to build on our past work delving into the mechanisms of bioprosthetic valve failure. Our data suggests that the mechanisms and timelines of valve degeneration are consistent across surgical and transcatheter bioprosthetic heart valves and a better understanding of structural valve degeneration can be obtained through combining further histological and novel imaging approaches. We will continue along this path of investigation through the generous support of the DeHaan Foundation Award which will allow us perform the needed advanced analyses to help advance our understanding of this complex process so that we can hopefully develop potential solutions to this important clinical problem."
PCR INNOVATORS DAY 2019
"It has been a great honor for Filterlex and myself to receive the Jon DeHaan Foundation Innovation Award.
We appreciate the recognition of the importance to protect the brain and the rest of the body during TAVR procedure. Filterlex carries the vision of procedural safety and the mission to deliver it in an easy and successful way. Although we are a start-up company, we see the patients in front of us, and aim to provide them with the best care.
With the generous Jon DeHaan Foundation grant, we will be able to further develop and soon to bring to patients a mature and improved device to protect them. We are now getting ready for the first-in-human experience, and thanks to your grant we will be able to move forward with these plans."
Dr. Kelly Han
“I truly appreciate this opportunity and [Mr. DeHaan’s] incredible generosity. One person can make a difference. With this grant, Mr DeHaan is making a very large difference in Cardiac Care.”
PCR Innovators Day 2019
Dr. William Wijns (PCR) and Dr. Robert Schwartz, President of the Jon DeHaan Foundation, talk to Award for Innovation in Cardiology winner, Giora Weisz, from the Montefiore Medical Center in New York, about his winning embolic protection device for use in TAVI procedures.